Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice
CEN Case Reports · 2024
DOI: 10.1007/s13730-024-00897-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift CEN Case Reports, 2024. Verfasst von Masayuki Maiguma und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Faculty of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo‑Ku, Tokyo, 113‑8421, Japan. Hauptthemen laut MEDLINE: Nephritis, Interstitial, Dietary Supplements, Biological Products. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Red yeast rice has been used to produce alcoholic beverages and various fermented foods especially in East Asia. Since around March 2024, there have been many cases of kidney dysfunction in people who have taken certain supplements containing red yeast rice in Japan. We experienced a case of acute kidney injuries induced after taking a supplement containing red yeast rice. A 58-year-old woman was admitted to our hospital due to renal dysfunction suspected to be caused by taking the supplement Benikoji CholesteHelp ® , which contains red yeast rice. With elevations of urinary tubular injury markers such as urinary β2-microglobulin and N -acetyl-β-D-glucosaminidase, serum creatinine levels were elevated up to 2.75 mg/dL. A kidney biopsy revealed a diagnosis of tubulointerstitial nephritis with lymphocytic infiltration of the interstitium, tubular atrophy, and interstitial fibrotic changes. After discontinuation of the supplement and initiation of the prednisolone treatment, renal dysfunction rapidly improved. The course of this case suggests tubular damage caused by the supplements containing red yeast rice. For early diagnosis and treatment, it should be noted that even what are regarded as nutritional health supplements can cause renal dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Faculty of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo‑Ku, Tokyo, 113‑8421, Japan.
- Department of Human Pathology, Faculty of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo‑Ku, Tokyo, 113‑8421, Japan.
- Department of Nephrology, Faculty of Medicine, Juntendo University, 2-1-1, Hongo, Bunkyo‑Ku, Tokyo, 113‑8421, Japan. yusuke@juntendo.ac.jp.
ORCID-Profile: Yusuke Suzuki
Zitieren
APA
Maiguma, M., Kihara, M., Hamaguchi, M., Kobayashi, T., Yamada, K., Takagi, M., Saeki, H., Gohda, T., & Suzuki, Y. (2024). Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice. CEN Case Reports. https://doi.org/10.1007/s13730-024-00897-9
Vancouver
Maiguma M, Kihara M, Hamaguchi M, Kobayashi T, Yamada K, Takagi M, et al. Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice. CEN Case Reports. 2024. doi:10.1007/s13730-024-00897-9
BibTeX
@article{Maiguma2024,
author = {Maiguma, Masayuki and Kihara, Masao and Hamaguchi, Maki and Kobayashi, Takashi and Yamada, Koshi and Takagi, Miyuki and Saeki, Harumi and Gohda, Tomohito and Suzuki, Yusuke},
title = {Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice},
journal = {CEN Case Reports},
year = {2024},
doi = {10.1007/s13730-024-00897-9}
}
EUVIMED